Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: May 20, 2019
Date Accepted: Oct 29, 2019
Date Submitted to PubMed: Jun 11, 2020

The final, peer-reviewed published version of this preprint can be found here:

Understanding and Addressing Variation in Health Care–Associated Infections After Durable Ventricular Assist Device Therapy: Protocol for a Mixed Methods Study

Chandanabhumma PP, Fetters MD, Pagani FD, Malani PN, Hollingsworth JM, Funk RJ, Aaronson KD, Zhang M, Kormos RL, Chenoweth CE, Shore S, Watt TM, Cabrera L, Likosky D

Understanding and Addressing Variation in Health Care–Associated Infections After Durable Ventricular Assist Device Therapy: Protocol for a Mixed Methods Study

JMIR Res Protoc 2020;9(1):e14701

DOI: 10.2196/14701

PMID: 31909721

PMCID: 6996720

Understanding and Addressing Variation in Healthcare-Associated Infections After Durable Ventricular Assist Device Therapy: Protocol for a Mixed Methods Study

  • P. Paul Chandanabhumma; 
  • Michael D Fetters; 
  • Francis D Pagani; 
  • Preeti N Malani; 
  • John M Hollingsworth; 
  • Russell J Funk; 
  • Keith D Aaronson; 
  • Min Zhang; 
  • Robert L Kormos; 
  • Carol E Chenoweth; 
  • Supriya Shore; 
  • Tessa M.F. Watt; 
  • Lourdes Cabrera; 
  • Donald Likosky

ABSTRACT

Background:

Background:

Durable Ventricular Assist Device (VAD) therapy is reserved for patients with advanced heart failure that have a poor estimated one-year survival. However, despite highly protocolized management processes, patients are at a unique risk for healthcare-associated infection (HAI). Few studies have examined optimal strategies for HAI prevention after durable VAD implantation, despite variability in rates across centers and their impact on short and long-term outcomes.

Objective:

Objective:

The objective of this study is to identify recommendations for preventing the most significant HAIs after durable VAD implantation. The study has three specific aims: 1) identify determinants of center-level variability in HAI rates 2) develop a comprehensive understanding of barriers and facilitators for achieving low center HAI rates and 3) develop and disseminate a best practices toolkit for preventing HAIs that accommodates various center contexts.

Methods:

Methods:

This is a sequential mixed methods study starting with a cross-sectional assessment of current practices. To address the first aim, we will conduct: (a) a systematic review of HAI prevention studies and (b) in-depth quantitative analyses using administrative claims, in-depth clinical data, and organizational surveys of VAD Centers. For the second aim, we will apply a mixed methods patient-tracer assessment framework to conduct semi-structured interviews, field observations and document analysis informed by Aim 1 findings at five high-performing (i.e. low HAIs) and five low-performing (i.e. high HAI) Centers, that will be examined using a mixed methods case series analysis. In aim three, we will build upon the findings from the previous aims to develop and field test an HAI preventive toolkit, acquire stakeholder input at an annual cardiac surgical conference, disseminate the final version to VAD Centers nationwide, and conduct follow-up surveys to assess the toolkit’s adoption.

Results:

Results:

We are currently conducting a systematic review of interventional HAI prevention studies and developing the survey addressing the determinants of HAI across VAD Centers.

Conclusions:

Conclusions:

This mixed methods study seeks to assess quantitatively determinants of HAIs across clinical centers and identify qualitatively context-specific facilitators and barriers for attaining low HAI rates. The mixed data findings will be used to develop and disseminate a stakeholder-acceptable toolkit of evidence-based HAI prevention recommendations that will accommodate the specific contexts and needs of VAD Centers.


 Citation

Please cite as:

Chandanabhumma PP, Fetters MD, Pagani FD, Malani PN, Hollingsworth JM, Funk RJ, Aaronson KD, Zhang M, Kormos RL, Chenoweth CE, Shore S, Watt TM, Cabrera L, Likosky D

Understanding and Addressing Variation in Health Care–Associated Infections After Durable Ventricular Assist Device Therapy: Protocol for a Mixed Methods Study

JMIR Res Protoc 2020;9(1):e14701

DOI: 10.2196/14701

PMID: 31909721

PMCID: 6996720

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.